Annals of Hepatology · 2012 · 37 citations · 11 references
MedicineInfectious DiseasesInternal MedicineAcute Care MedicineHepatologyInfectious Disease EpidemiologyAcute Liver FailureAcute Viral Hepatitis ManagementHepatic PathologyLiver DiseaseViral HepatitisViral Hepatitis TreatmentAcute Hepatitis ManagementAcute Liver Failure ManagementBlood Urea Nitrogen To Creatinine RatioHepatitis A Virus InfectionInfection Risk FactorsSevere Acute IllnessTreatment Of Hepatitis AViral Hepatitis-associated Liver Failure
BACKGROUND: Hepatitis A is the most common type of viral hepatitis in Mexico. The change of hepatitis A epidemiology in Mexico from high to intermediate endemicity leads to increasing susceptible adults for severe illness. OBJECTIVE: To describe the clinical characteristics and hospital outcome of adult patients with acute hepatitis A infection, and determine risk factor for mortality. MATERIAL AND METHODS: This is a retrospective observational, multicentre study in Mexico City and in Guatemala City. All inhospital patients were followed until discharge or death. Risk factors for death/acute liver failure were identified. RESULTS: Forty seven patients were analyzed, sixty percent were male, the prodrome phase was from 3 to 30 days. The three most common symptoms were fever, malaise and jaundice, with 87%, 74% and 62% respectively. The incidence of patients who were treated with antibiotics before hospital admission was up to 34%. Unnecessary imaging studies and out of guidelines drugs were used. Presence of encephalopathy, leukocytes > 19,000/mL, blood urea nitrogen > 36 mg/dL, creatinine > 2 mg/dL, albumin < 2.5 mg/dL and total bilirubin > 9.6 mg/dL, are predictors of mortality. Serum creatinine > 2 mg/dL has the best sensibility and specificity for predicting fulminant hepatitis/death. CONCLUSION: Acute hepatitis A infection in adults is associated some unnecessary diagnostic and therapeutic approach. Could be associated with fulminant hepatitis, and a creatinine value > 2 mg/dL is the best predictor for fulminant hepatitis and death.
11
Hepatitis A shifting epidemiology in Latin America
Jorge Tanaka · Vaccine · 2000 · 185 citations
[Epidemiology of viral hepatitis in Mexico].
Arturo Panduro, Griselda Escobedo Meléndez, Nora A. Fierro et al. · PubMed · 2011 · 75 citations
Medicine, Infectious Disease Control, Infectious Diseases +14